JP4884228B2 - タキソイド−脂肪酸コンジュゲート及びその医薬組成物 - Google Patents

タキソイド−脂肪酸コンジュゲート及びその医薬組成物 Download PDF

Info

Publication number
JP4884228B2
JP4884228B2 JP2006538315A JP2006538315A JP4884228B2 JP 4884228 B2 JP4884228 B2 JP 4884228B2 JP 2006538315 A JP2006538315 A JP 2006538315A JP 2006538315 A JP2006538315 A JP 2006538315A JP 4884228 B2 JP4884228 B2 JP 4884228B2
Authority
JP
Japan
Prior art keywords
cancer
taxoid
dha
conjugate
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2006538315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007510648A (ja
JP2007510648A5 (enExample
Inventor
イワオ オジマ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of JP2007510648A publication Critical patent/JP2007510648A/ja
Publication of JP2007510648A5 publication Critical patent/JP2007510648A5/ja
Application granted granted Critical
Publication of JP4884228B2 publication Critical patent/JP4884228B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2006538315A 2003-10-30 2004-10-28 タキソイド−脂肪酸コンジュゲート及びその医薬組成物 Expired - Lifetime JP4884228B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51578303P 2003-10-30 2003-10-30
US60/515,783 2003-10-30
PCT/US2004/036027 WO2005041881A2 (en) 2003-10-30 2004-10-28 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof

Publications (3)

Publication Number Publication Date
JP2007510648A JP2007510648A (ja) 2007-04-26
JP2007510648A5 JP2007510648A5 (enExample) 2007-12-13
JP4884228B2 true JP4884228B2 (ja) 2012-02-29

Family

ID=34549443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538315A Expired - Lifetime JP4884228B2 (ja) 2003-10-30 2004-10-28 タキソイド−脂肪酸コンジュゲート及びその医薬組成物

Country Status (7)

Country Link
US (1) US7820839B2 (enExample)
EP (1) EP1703904B1 (enExample)
JP (1) JP4884228B2 (enExample)
CN (1) CN1901901B (enExample)
AU (1) AU2004285529A1 (enExample)
CA (1) CA2544128A1 (enExample)
WO (1) WO2005041881A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2544128A1 (en) 2003-10-30 2005-05-12 The Research Foundation Of State University Of New York Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
WO2007021957A2 (en) 2005-08-12 2007-02-22 Research Foundation Of State University Of New York Fluorotaxoids
WO2008021242A2 (en) * 2006-08-10 2008-02-21 The Research Foundation Of State University Of New York Fluorotaxoid-fatty acid conjugates and pharmaceutical compositions thereof
CN101225094A (zh) * 2007-01-18 2008-07-23 天津和美生物技术有限公司 具有抗癌活性的蒽醌四环类化合物
US20090022727A1 (en) 2007-01-26 2009-01-22 Alza Corp. Injectable, nonaqueous suspension with high concentration of therapeutic agent
US9763905B2 (en) 2013-03-15 2017-09-19 The Children's Medical Center Corporation Therapeutic target for the treatment of cancers and related therapies and methods
CN106390122A (zh) * 2015-07-31 2017-02-15 舟山三合生物科技有限公司 化疗类抗癌药口服制剂组合物
CN105343004A (zh) * 2015-09-14 2016-02-24 东北林业大学 一种二十二碳六烯酸靶向多西紫杉醇纳米药物的制备方法
EP3463299A4 (en) * 2016-06-07 2020-01-15 Targagenix, Inc. TAXOID NANOEMULSION COMPOSITIONS, AND METHODS OF USE THEREOF FOR TARGETING CANCER CELLS AND CANCER STEM CELLS
JP7450888B2 (ja) * 2017-12-20 2024-03-18 タルガジェニックス，インコーポレイテッド がんにおける免疫療法との併用タキソイドナノエマルジョン
CN110201182B (zh) * 2019-06-21 2022-09-27 山东大学 一种紫杉醇-dha-右旋糖酐偶联聚合物及其合成方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
JP2000511188A (ja) * 1996-05-22 2000-08-29 ニューロメディカ インコーポレーテッド シス―ドコサヘキサエン酸とｔａｘ―その他との共有複合体を含有する製剤
JP2000511187A (ja) * 1996-05-22 2000-08-29 ニューロメディカ インコーポレーテッド シス―ドコサヘキサエン酸およびパクリタクセルの複合体
JP2000514405A (ja) * 1996-05-22 2000-10-31 プロタルガ インコーポレーテッド Ｄｈａ―薬剤複合体
US6458976B1 (en) * 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500858B2 (en) * 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6576636B2 (en) * 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
CN1377282A (zh) * 1999-03-09 2002-10-30 普罗塔盖公司 脂肪酸－抗癌缀合物及其应用
CA2544128A1 (en) 2003-10-30 2005-05-12 The Research Foundation Of State University Of New York Taxoid-fatty acid conjugates and pharmaceutical compositions thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6458976B1 (en) * 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
JP2000511188A (ja) * 1996-05-22 2000-08-29 ニューロメディカ インコーポレーテッド シス―ドコサヘキサエン酸とｔａｘ―その他との共有複合体を含有する製剤
JP2000511187A (ja) * 1996-05-22 2000-08-29 ニューロメディカ インコーポレーテッド シス―ドコサヘキサエン酸およびパクリタクセルの複合体
JP2000514405A (ja) * 1996-05-22 2000-10-31 プロタルガ インコーポレーテッド Ｄｈａ―薬剤複合体

Also Published As

Publication number Publication date
JP2007510648A (ja) 2007-04-26
WO2005041881A3 (en) 2005-12-08
CA2544128A1 (en) 2005-05-12
EP1703904B1 (en) 2013-02-13
CN1901901B (zh) 2012-07-04
CN1901901A (zh) 2007-01-24
EP1703904A2 (en) 2006-09-27
US20070088076A1 (en) 2007-04-19
EP1703904A4 (en) 2011-01-19
US7820839B2 (en) 2010-10-26
AU2004285529A1 (en) 2005-05-12
WO2005041881A8 (en) 2006-06-29
WO2005041881A2 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
JP4172725B2 (ja) シス―ドコサヘキサエン酸およびパクリタクセルの複合体
Botta et al. Synthesis and biological evaluation of new taxoids derived from 2-deacetoxytaxinine J
JP4884228B2 (ja) タキソイド−脂肪酸コンジュゲート及びその医薬組成物
KR102762016B1 (ko) 니트록솔린 전구약물 및 이의 용도
US10143677B2 (en) Taxane analogs for the treatment of brain cancer
AU4787693A (en) Protein kinase inhibitors and related compounds combined with taxol
Wang et al. Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo
Feng et al. Synthesis and evaluation of water-soluble paclitaxel prodrugs
Nakagawa-Goto et al. Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant—taxoid conjugates as novel cytotoxic agents
Lin et al. Recent strategies in the development of taxane anticancer drugs
WO2009090614A2 (en) Derivatives of taxol and closely related compounds
EP1248776B1 (en) Semi-synthetic taxanes with antitumor and antiangiogenetic activities
JP5622856B2 (ja) キサントン誘導体およびその用途
US20090163450A1 (en) Combinations comprising a prostaglandin and uses thereof
Lu et al. Design, synthesis and biological evaluation of novel fluorinated docetaxel analogues
EP1263749A1 (en) Taxane anticancer agents
AU2001245582A1 (en) Taxane anticancer agents
Dubois et al. Recent developments in antitumour taxoids
Pepe Synthetic and biological studies on new anti-tumor agents
US7615653B2 (en) Anti-tuberculosis taxane compounds
US20050054716A1 (en) Pharmaceutical compositions and methods of using taxane derivatives
Wang Efforts towards Development of New Generation Taxoids: SAR Study, Combination Treatment, and Gold Nanoparticle Drug Delivery System
WO2008021242A2 (en) Fluorotaxoid-fatty acid conjugates and pharmaceutical compositions thereof
Parasram Synthesis of Next Generation Taxanes and Tumor-Targeting Taxane-Based Drug Conjugates using Linolenic Acid as Tumor-Targeting Module
TWI286552B (en) C10 carbonate substituted taxanes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071029

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071029

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100927

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101224

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110106

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110728

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20110808

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110920

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111005

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111107

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111206

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141216

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4884228

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term